489 related articles for article (PubMed ID: 22867045)
1. Analgesics in patients with hepatic impairment: pharmacology and clinical implications.
Bosilkovska M; Walder B; Besson M; Daali Y; Desmeules J
Drugs; 2012 Aug; 72(12):1645-69. PubMed ID: 22867045
[TBL] [Abstract][Full Text] [Related]
2. Acute pain management pharmacology for the patient with concurrent renal or hepatic disease.
Murphy EJ
Anaesth Intensive Care; 2005 Jun; 33(3):311-22. PubMed ID: 15973913
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of opioids in liver disease.
Tegeder I; Lötsch J; Geisslinger G
Clin Pharmacokinet; 1999 Jul; 37(1):17-40. PubMed ID: 10451781
[TBL] [Abstract][Full Text] [Related]
4. [Therapy with opioids in liver or renal failure].
Tegeder I; Geisslinger G; Lötsch J
Schmerz; 1999 Jun; 13(3):183-95. PubMed ID: 12799931
[TBL] [Abstract][Full Text] [Related]
5. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
6. [Opioids in patients with renal impairment].
Pfefferkorn F; Harings-Kaim A; Schönenberger M; Leuppi-Taegtmeyer A
Ther Umsch; 2020; 77(1):10-13. PubMed ID: 32486992
[TBL] [Abstract][Full Text] [Related]
7. [Opioids for Cancer Pain and its Use under Particular Conditions: A Narrative Review].
Vieira C; Brás M; Fragoso M
Acta Med Port; 2019 May; 32(5):388-399. PubMed ID: 31166900
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project.
King S; Forbes K; Hanks GW; Ferro CJ; Chambers EJ
Palliat Med; 2011 Jul; 25(5):525-52. PubMed ID: 21708859
[TBL] [Abstract][Full Text] [Related]
9. The use of major analgesics in patients with renal dysfunction.
Niscola P; Scaramucci L; Vischini G; Giovannini M; Ferrannini M; Massa P; Tatangelo P; Galletti M; Palumbo R
Curr Drug Targets; 2010 Jun; 11(6):752-8. PubMed ID: 20041843
[TBL] [Abstract][Full Text] [Related]
10. Oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe, chronic cancer pain: Challenges in the context of hepatic impairment.
Le BH; Aggarwal G; Douglas C; Green M; Nicoll A; Ahmedzai S
Asia Pac J Clin Oncol; 2022 Feb; 18(1):13-18. PubMed ID: 33660420
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.
Verbeeck RK
Eur J Clin Pharmacol; 2008 Dec; 64(12):1147-61. PubMed ID: 18762933
[TBL] [Abstract][Full Text] [Related]
12. "Weak" opioid analgesics. Codeine, dihydrocodeine and tramadol: no less risky than morphine.
Prescrire Int; 2016 Feb; 25(168):45-50. PubMed ID: 27042732
[TBL] [Abstract][Full Text] [Related]
13. [Opioids during anesthesia in liver and renal failure].
Höhne C; Donaubauer B; Kaisers U
Anaesthesist; 2004 Mar; 53(3):291-303. PubMed ID: 15074320
[TBL] [Abstract][Full Text] [Related]
14. The pharmacokinetics of oxycodone and its metabolites following single oral doses of Remoxy®, an abuse-deterrent formulation of extended-release oxycodone, in patients with hepatic or renal impairment.
Malhotra BK; Schoenhard GL; de Kater AW; Friedmann N
J Opioid Manag; 2015; 11(2):157-69. PubMed ID: 25901481
[TBL] [Abstract][Full Text] [Related]
15. [Pain management in patients with liver cirrhosis].
Ojeda A; Moreno LA
Gastroenterol Hepatol; 2014 Jan; 37(1):35-45. PubMed ID: 24309482
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.
De Paepe P; Belpaire FM; Buylaert WA
Clin Pharmacokinet; 2002; 41(14):1135-51. PubMed ID: 12405864
[TBL] [Abstract][Full Text] [Related]
17. [Opioid therapy in patients with liver cirrhosis].
Krähenbühl S
Ther Umsch; 2020; 77(1):14-19. PubMed ID: 32486995
[TBL] [Abstract][Full Text] [Related]
18. Opioid analgesics-related pharmacokinetic drug interactions: from the perspectives of evidence based on randomized controlled trials and clinical risk management.
Feng XQ; Zhu LL; Zhou Q
J Pain Res; 2017; 10():1225-1239. PubMed ID: 28579821
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
